Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) University of Pennsylvania |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00078130 |
The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.
Condition | Intervention | Phase |
---|---|---|
Opioid-Related Disorders |
Drug: Buprenorphine/naloxone |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment |
Official Title: | Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents |
Ages Eligible for Study: | 14 Years to 21 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.
United States, Maine | |
Mercy Hospital | |
Portland, Maine, United States, 04092 | |
United States, Maryland | |
Mountain Manor | |
Baltimore, Maryland, United States, 21229 | |
United States, New Mexico | |
ASAP | |
Albuquerque, New Mexico, United States, 87106 | |
United States, North Carolina | |
Duke Addictions Program | |
Durham, North Carolina, United States, 27710 |
Principal Investigator: | George Woody, M.D. | University of Pennsylvania |
Study ID Numbers: | NIDA-CTN-0010-1 |
Study First Received: | February 19, 2004 |
Last Updated: | July 28, 2008 |
ClinicalTrials.gov Identifier: | NCT00078130 |
Health Authority: | United States: Food and Drug Administration |
Buprenorphine Mental Disorders Substance-Related Disorders |
Disorders of Environmental Origin Opioid-Related Disorders Naloxone |
Sensory System Agents Therapeutic Uses Narcotic Antagonists Physiological Effects of Drugs Central Nervous System Depressants Narcotics |
Peripheral Nervous System Agents Analgesics Central Nervous System Agents Pharmacologic Actions Analgesics, Opioid |